Health Trials

Fibrosis and Cirrhosis of Liver

2

Review clinical trials related to Fibrosis and Cirrhosis of Liver. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

The purpose of this study is to assess the safety and efficacy of RTX001 in patients with end-stage liver disease. This study is the first time RTX001, a macrophage cell therapy engineered to have an anti-inflammatory and anti-fibrotic effect, will be given to humans.

Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Resolution Therapeutics LimitedUpdated: Jan 28, 2026Locations: 14
Eligibility criteria

Male or female age ≥18-75 years. [+12]

any viral hepatitidies, or [+33]

Read more
Status: Not yet recruiting

Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB

This study aims to evaluate diagnostic performance of CT attenuation parameters acquired using deep learning algorithm in assessing hepatic steatosis and fibrosis.

Participants needed: 111
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Seoul National University HospitalUpdated: Sep 27, 2024Locations: 1Duration: 1 Year
Eligibility criteria

chronic hepatitis B [+2]

pregnant women [+4]

Read more